ERBB2 and breast cancer: Using this newly established NOTCH signature, we investigated BC patient data from the TCGA and METABRIC databases across subgroups (luminal, HER2+ and TNBC) and categorized patients into three groups based on expression scores of the signature (NOTCHHigh–NOTCHInt–NOTCHLow).